Olivo Martin Sebastian 4
4 · Protara Therapeutics, Inc. · Filed Apr 20, 2021
Insider Transaction Report
Form 4
Olivo Martin Sebastian
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-19+120,000→ 120,000 totalExercise: $15.30Exp: 2031-04-18→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]One-fourth of the shares shall vest on April 19, 2022 and the remainder of the shares will vest in a series of thirty-six successive equal monthly installments measured from April 19, 2022, subject to the Reporting Person's Continuous Service (as defined in the Inducement Plan) with the Issuer through each such vesting date.